Quality of life one year post‐Shiga toxin‐producing Escherichia coli O104 infection – A prospective cohort study

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 3, 2015-03 ,pp. : 370-378

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction of Protection against Oral Infection with Cytotoxin–Producing Escherichia coli O157:H7 in Mice by Shiga–like Toxin–Liposome Conjugate

By  

International Archives of Allergy and Immunology, Vol. 116, Iss. 4, 1998-08 ,pp. : 313-317

Karger

Access to resources Recommend Favorite

Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: An empiric study

By Jensen Charlotte   Schiellerup Peter   Olsen Katharina   Scheutz Flemming   Petersen Eskild   Gerner-Smidt Peter   Mølbak Kåre  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 1, 2005-01 ,pp. : 61-63

Informa Healthcare

Access to resources Recommend Favorite

Antimicrobial therapy and shedding time of Shiga toxin-producing Escherichia coli

By Ichinohe Sadato   Ichinohe Naoko   Sakuma Fumiako  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 11-12, 2008-11 ,pp. : 1002-1003

Informa Healthcare

Access to resources Recommend Favorite

Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli

By Alsterlund Rolf   Axelsson Carolina   Olsson-Liljequist Barbro  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 1, 2012-01 ,pp. : 51-54

Informa Healthcare

Access to resources Recommend Favorite